Avricore Health Inc. (AVCRF)
OTCMKTS
· Delayed Price · Currency is USD
0.0424
0.00 (0.00%)
Jun 5, 2025, 8:00 PM EDT
Avricore Health Revenue
Avricore Health had revenue of 434.06K CAD in the quarter ending March 31, 2025, a decrease of -61.39%. This brings the company's revenue in the last twelve months to 4.10M, up 2.90% year-over-year. In the year 2024, Avricore Health had annual revenue of 4.79M with 37.32% growth.
Revenue (ttm)
4.10M CAD
Revenue Growth
+2.90%
P/S Ratio
1.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.07M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.79M | 1.30M | 37.32% |
Dec 31, 2023 | 3.49M | 1.72M | 97.08% |
Dec 31, 2022 | 1.77M | 1.65M | 1,339.95% |
Dec 31, 2021 | 122.81K | 89.78K | 271.81% |
Dec 31, 2020 | 33.03K | 30.00 | 0.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Avricore Health News
- 5 weeks ago - AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track - GlobeNewsWire
- 4 months ago - HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK - GlobeNewsWire
- 6 months ago - Avricore Health Corporate Update: Effective Plan, Resources Result in Success - GlobeNewsWire
- 7 months ago - Avricore Health Refocuses Strategy to Unlock Growth Potential - GlobeNewsWire
- 7 months ago - Avricore Health Recognized in Deloitte's 2024 Technology Fast 50™ Companies to Watch - GlobeNewsWire
- 10 months ago - Avricore Grants Options - GlobeNewsWire
- 10 months ago - Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability - GlobeNewsWire
- 1 year ago - Avricore Health Corporate Update and Audited Results for 2023 - GlobeNewsWire